NEW YORK, Sept. 7 (GenomeWeb News) - Sangamo BioSciences has licensed its zinc finger DNA-binding protein technology to Novo Nordisk, the companies said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.
Technology Review points out that a new US presidential science advisor hasn't been selected.
Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.
President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.